|
|
|
Insider
Information: |
Sullivan Louis |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
195,903 |
|
Indirect Shares
|
20,185 |
|
|
Direct
Value |
$10,090,878 |
|
|
Indirect Value
|
$1,969,249 |
|
|
Total
Shares |
216,088 |
|
|
Total
Value |
$12,060,127 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
-4.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2011-08-15 |
47,898 |
2003-07-17 |
0 |
Premium* |
|
3M Co |
MMM |
Director |
2006-05-09 |
1,722 |
2006-05-09 |
20,185 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2005-04-29 |
8,399 |
2004-04-23 |
0 |
Premium* |
|
Equifax Inc |
EFX |
Director |
2004-05-05 |
6,033 |
2004-05-05 |
0 |
Premium* |
|
Henry Schein Inc |
HSIC |
Director |
2016-03-04 |
14,096 |
2005-03-18 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-05-03 |
13,060 |
2007-12-11 |
0 |
Premium* |
|
Emergent Biosolutions Inc. |
EBS |
Director |
2024-05-23 |
104,695 |
2010-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
UTHR |
United Therapeutics Corp |
Director |
|
2018-10-01 |
4 |
D |
$125.96 |
$125,960 |
D/D |
(1,000) |
3,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-11-01 |
4 |
D |
$115.04 |
$115,040 |
D/D |
(1,000) |
1,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-12-03 |
4 |
D |
$119.53 |
$119,530 |
D/D |
(1,000) |
1,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-01-02 |
4 |
D |
$107.65 |
$107,650 |
D/D |
(1,000) |
1,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-02-01 |
4 |
D |
$115.83 |
$115,830 |
D/D |
(1,000) |
1,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-03-01 |
4 |
D |
$126.84 |
$126,840 |
D/D |
(1,000) |
1,370 |
0 |
- |
|
EBS |
Emergent Biosolutions Inc... |
Director |
|
2019-05-07 |
4 |
D |
$49.41 |
$105,490 |
D/D |
(2,135) |
54,730 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2020-03-23 |
4 |
D |
$83.95 |
$503,700 |
D/D |
(6,000) |
7,120 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2020-03-25 |
4 |
D |
$90.54 |
$1,358,100 |
D/D |
(15,000) |
7,120 |
0 |
- |
|
EBS |
Emergent Biosolutions Inc... |
Director |
|
2021-05-10 |
4 |
D |
$61.62 |
$192,131 |
D/D |
(3,118) |
39,945 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2021-05-11 |
4 |
D |
$194.30 |
$5,829,000 |
D/D |
(30,000) |
9,420 |
0 |
- |
|
EBS |
Emergent Biosolutions Inc... |
Director |
|
2020-09-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,004 |
32,758 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2004-04-23 |
4 |
OE |
$13.15 |
$55,322 |
D/D |
4,207 |
8,919 |
|
- |
|
EFX |
Equifax Inc |
Director |
|
2004-05-05 |
4 |
OE |
$21.53 |
$72,737 |
D/D |
3,378 |
8,984 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2004-10-22 |
4 |
OE |
$2.85 |
$35,625 |
D/D |
12,500 |
27,898 |
|
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2005-03-18 |
4 |
OE |
$21.70 |
$10,850 |
D/D |
500 |
500 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2005-04-29 |
4 |
OE |
$15.44 |
$64,956 |
D/D |
4,207 |
10,918 |
|
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2007-12-11 |
4 |
OE |
$16.30 |
$408,644 |
D/D |
20,213 |
20,213 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2010-08-09 |
4 |
OE |
$11.64 |
$14,916 |
D/D |
1,282 |
1,282 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2010-08-12 |
4 |
OE |
$12.64 |
$303,360 |
D/D |
24,000 |
24,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2010-10-28 |
4 |
OE |
$22.57 |
$9,026 |
D/D |
400 |
400 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2010-10-29 |
4 |
OE |
$22.57 |
$126,364 |
D/D |
5,600 |
5,600 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2011-01-03 |
4 |
OE |
$24.39 |
$146,340 |
D/D |
6,000 |
6,000 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2011-03-01 |
4 |
OE |
$24.39 |
$146,340 |
D/D |
6,000 |
6,000 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2011-03-15 |
4 |
OE |
$21.70 |
$423,150 |
D/D |
19,500 |
37,212 |
0 |
- |
|
170 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|